Literature DB >> 12643900

Prodrugs to enhance central nervous system effects of the TRH-like peptide pGlu-Glu-Pro-NH2.

Katalin Prokai-Tatrai1, Vien Nguyen, Alevtina D Zharikova, April C Braddy, Stanley M Stevens, Laszlo Prokai.   

Abstract

Potential prodrugs for the TRH-like tripeptide pGlu-Glu-Pro-NH(2) were synthesized either by esterifying the Glu side-chain of the parent peptide in solution with alcohols in the presence of resin-bound dicyclohexylcarbodiimide or by solid-phase peptide chemistry. Affinities of these ester prodrugs to lipid membranes as predictors of the transport across the blood-brain barrier were compared by immobilized artificial membrane chromatography, and prodrug activation was tested in the brain tissue of experimental animals. Esters of pGlu-Glu-Pro-NH(2) with long-chain primary alcohols emerged as potentially useful prodrugs to improve the central nervous system activity of pGlu-Glu-Pro-NH(2) upon systemic administration, as revealed by the enhancement of analeptic activity in mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12643900     DOI: 10.1016/s0960-894x(03)00081-7

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Factors that contribute to the misidentification of tyrosine nitration by shotgun proteomics.

Authors:  Stanley M Stevens; Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  Mol Cell Proteomics       Date:  2008-08-16       Impact factor: 5.911

2.  [Glu2]TRH dose-dependently attenuates TRH-evoked analeptic effect in mice.

Authors:  Vien Nguyen; Alevtina D Zharikova; Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  Brain Res Bull       Date:  2010-02-24       Impact factor: 4.077

3.  Exploratory neuropharmacological evaluation of a conformationally constrained thyrotropin-releasing hormone analogue.

Authors:  Meritxell Teixidó; Katalin Prokai-Tatrai; Xiaoli Wang; Vien Nguyen; Laszlo Prokai
Journal:  Brain Res Bull       Date:  2007-03-15       Impact factor: 4.077

Review 4.  Hybrids: a new paradigm to treat Alzheimer's disease.

Authors:  Manjinder Singh; Maninder Kaur; Navriti Chadha; Om Silakari
Journal:  Mol Divers       Date:  2015-09-02       Impact factor: 2.943

5.  Design and exploratory neuropharmacological evaluation of novel thyrotropin-releasing hormone analogs and their brain-targeting bioprecursor prodrugs.

Authors:  Katalin Prokai-Tatrai; Vien Nguyen; Szabolcs Szarka; Krisztina Konya; Laszlo Prokai
Journal:  Pharmaceutics       Date:  2013       Impact factor: 6.321

6.  Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate).

Authors:  Naotake Kobayashi; Norihito Sato; Yuko Fujimura; Tsuyoshi Kihara; Katsuji Sugita; Kouji Takahashi; Katsumi Koike; Tamio Sugawara; Yukio Tada; Hiroshi Nakai; Takayoshi Yoshikawa
Journal:  ACS Omega       Date:  2018-10-19

Review 7.  Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents.

Authors:  Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  Molecules       Date:  2009-02-06       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.